Patient characteristics, treatment patterns, and clinical outcomes in patients hospitalized with factor Xa inhibitor-associated major bleeds: A report from the REVERXaL study.
Saved in:
| Title: | Patient characteristics, treatment patterns, and clinical outcomes in patients hospitalized with factor Xa inhibitor-associated major bleeds: A report from the REVERXaL study. |
|---|---|
| Authors: | Alikhan R; University Hospital of Wales and Cardiff University School of Medicine, Cardiff, UK. Electronic address: Raza.Alikhan@wales.nhs.uk., Nour M; University of California, Los Angeles, CA, USA., Tiede A; Hannover Medical School, Hannover, Germany., Ofori-Asenso R; AstraZeneca, Cambridge, UK., Yasaka M; Fukuoka Neurosurgical Hospital, Fukuoka, Japan., Chen H; AstraZeneca, Wilmington, DE, USA., Sehgal V; University College London Hospital, London, UK., Yokobori S; Nippon Medical School, Tokyo, Japan., Odelade O; AstraZeneca, Cambridge, UK., Cash BD; Baylor Scott & White, Baylor University Medical Center, Dallas, TX, USA., Maegele M; Cologne-Merheim Medical Center (CMMC), Institute for Research in Operative Medicine (IFOM), Witten/Herdecke University, Cologne, Germany., Singer AJ; Renaissance School of Medicine at Stony Brook University, New York, NY, USA. |
| Source: | Thrombosis research [Thromb Res] 2026 Apr; Vol. 260, pp. 109650. Date of Electronic Publication: 2026 Mar 10. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-2472 (Electronic) Linking ISSN: 00493848 NLM ISO Abbreviation: Thromb Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
